ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0593

Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA

Angela Bedenbaugh1, Vinson Lee1, Gary Oderda2, Sarah Kennedy1, Jeyanesh Tambiah1, Diana Brixner2 and Timothy McAlindon3, 1Samumed, LLC, San Diego, CA, 2University of Utah, Salt Lake City, UT, 3Tufts Medical Center, Boston, MA

Meeting: ACR Convergence 2020

Keywords: Epidemiology, Osteoarthritis, surgery, Total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Health Services Research Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Total knee replacement (TKR) is considered an effective knee OA treatment and is a commonly performed orthopedic procedure that relieves pain and improves function and quality of life.1 However, up to 20% of patients may not achieve good clinical outcomes.2 Also, comorbidities and patient factors may limit the ability to safely perform the TKR. The objective of this was to identify the percentage and distribution of TKR surgical candidates across specialties (rheumatologists [RH], orthopedic surgeons [OS], sports medicine [SM] physicians, and pain specialists [PS]) to gain insight into patient characteristics influencing TKR candidacy.

Methods: Board-certified physicians with >2 years in practice and >10 knee OA patients per week participated in an interview about their two most recent knee OA patients. Interviews were conducted from March to April 2019 and assessed demographics, referral patterns, comorbidities, time to treatment, imaging use, candidacy for TKR, and reasons for noncandidacy. Multiple reasons for TKR noncandidacy per patients were allowed. Since no patient-identifying information was included, this project was exempt from IRB review and HIPAA consent. As this study was designed to assess multiple characteristics and associated effect modifications, a confidence level of 90% was used.3

Results: Overall, the mean age of knee OA patients was 65 years (range: 63 years for SM patients to 66 years for PS patients) (Table 1). Primary care physicians were the most common referrers to RH (83%) and the reported mean time from symptom onset to diagnosis was 3.4 years (longest in RH patients; 4.5 years). Overall, the mean number of comorbidities was 2.6, with the most common being hypertension and obesity (Table 2). The mean pain score was 5.5 (0–10 NRS) and 58% of RH patients had moderate pain. RH saw predominantly KL grade 3 (55.6%) patients whereas OS saw more KL grade 4 (45.3%) patients. TKR candidacy was assessed for 779 patients; approximately half of these were identified as future surgical candidates, with 38% projected to undergo TKR within the next 12 months. Overall, of 286 (37%) identified as TKR noncandidates, 65% had mild disease or well-controlled symptoms. Among RH noncandidates (42%, n=105), additional reasons for TKR exclusion included patient preference (30%), age (11%), overall health (10%), weight (5%), and smoking habits (5%) (Table 2). Limitations to this study included potential selection bias, confounding by risk factors, inability to show causation, small n’s, missing data, and pre-COVID-19 proposed timeline for TKR.

Conclusion: In this observational chart review, of the 42% of TKR noncandidates who were RH patients, several patient factors were identified as reasons for exclusion (patient preference, age, overall health, and lifestyle choices [such as smoking]). Patient preference contributed the largest impact (30%) and other influences were well characterized, suggesting further investigation of patient-focused factors that impact decision-making regarding TKR is warranted.

References:

  1. NEJM 2015; 373:1597-1606
  2. EFORT Open Rev. 2018;3(8):461‐470
  3. J Thorac Dis. 2016 Sep; 8(9): E928–E931


Disclosure: A. Bedenbaugh, Samumed, 3; V. Lee, Samumed, 5; G. Oderda, Samumed, LLC, 5; S. Kennedy, Samumed, LLC, 1, 3; J. Tambiah, Samumed LLC, 1, 3, Samumed LLC, 1, 3; D. Brixner, Samumed, 5; T. McAlindon, Pfizer, 1, Sanofi Aventis US, 1, Kolon Tissuegene, 1, Samumed, 1, Seikagaku, 1, Kiniksa Pharmaceuticals, 1, Anika Therapeutics, 1.

To cite this abstract in AMA style:

Bedenbaugh A, Lee V, Oderda G, Kennedy S, Tambiah J, Brixner D, McAlindon T. Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/patient-characteristics-and-factors-affecting-decision-making-regarding-total-knee-replacement-by-different-types-of-physicians-treating-patients-with-knee-oa/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-characteristics-and-factors-affecting-decision-making-regarding-total-knee-replacement-by-different-types-of-physicians-treating-patients-with-knee-oa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology